Combimist L Inhaler
A levosalbutamol and ipratropium inhaler for bronchospasm and asthma. It contains two bronchodilators, opening the airways through two different pathways.
- Category
- Respiratory Health
- Active ingredients
- Levosalbutamol · Ipratropium
- Route
- Inhalation use
- Form
- Inhaler
- Strengths
- 50mcg + 20mcg
Prescription and consultation requirements for Combimist L Inhaler vary by destination and are determined by the fulfilment partner.
Combimist L Inhaler details
- Conditions
- Bronchospasm · Asthma · Chronic Obstructive Pulmonary Disease
- Alternative names
- levosalbutamol, ipratropium
- Therapeutic class
- Beta-2 Adrenergic Agonist, Anticholinergic Combination
- Pharmacological class
- Bronchodilator Combination
- Contraindications
- hypersensitivity to ipratropium; history of cardiac tachyarrhythmias
- Minor side effects
- dry mouth; cough; headache
- Moderate side effects
- throat irritation; tachycardia; tremor
- Dosage forms
- Inhaler
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Lupin Ltd
- Onset Time
- 15 minutes
- Duration
- 6–8 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Beta Blockers; Diuretics; Tiotropium
- Age restrictions
- Approved for patients over six years of age.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; narrow-angle glaucoma flare, requires immediate medical attention
Patient summary
A levosalbutamol and ipratropium inhaler for bronchospasm and asthma. It contains two bronchodilators, opening the airways through two different pathways.
Mechanism of action
Levosalbutamol relaxes airways via beta-2 activation while ipratropium blocks acetylcholine-mediated airway constriction in smooth muscles.
Pregnancy and breastfeeding
Pregnancy: Use if potential benefits outweigh risks. Breastfeeding: Consult a clinician.